SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1805A first for me: Brean Murray Update, February 07, 2006.. Dr. Jonathan Aschoff szeta1961-2/15/2006
1804It's that Fluffer Nutter on Wonder Bread predilection that won't quit &zeta1961-2/15/2006
1803cluster of options exercises coupled to sells from senior management. these guyscaram(o)uche-2/14/2006
1802Thanks Jon..I didn't know it was common knowledge failure was a given and thzeta1961-2/11/2006
1801Thanks Jon..I didn't know it was common knowledge failure was a given and thzeta1961-2/11/2006
1800Hey, thanks! There aren't many who cover that much ground. :-) Rickscaram(o)uche-2/11/2006
1799Here's a recent Mayo Clinic patent application, a continuation of 6,911,466 sim1-2/11/2006
1798If memory serves, they think the prostate trial was poorly designed and do expecRobohogs-2/11/2006
1797Except it will take 10-12 months to get approval once data has been tabulated anRobohogs-2/11/2006
1796I saw a report this afternoon by CSFB(Dec. 05)..very bearish, even going so far zeta1961-2/10/2006
1795<i>it was the implication that the second one was an option to be determinzeta1961-2/10/2006
1794It is even messier than you suggest. The option to stop is after the last subjeA.J. Mullen-2/10/2006
1793Good retrieval on that one. But the difference is--the intention to continue andNeuroInvestment-2/10/2006
1792Most pivotal trials in age-related macular degeneration have one-year and two-yeDewDiligence_on_SI-2/10/2006
1791Presenting preclinical HIV data at a "major scientific meeting" and wrscaram(o)uche-2/9/2006
17909-Feb-06 JMP Securities Upgrade: Mkt Outperform to Strong Buy Poster claimed 2Doc Bones-2/9/2006
1789The more I think about this--which still isn't much--the more puzzling it seNeuroInvestment-2/8/2006
1788<i>The argument (not yours) that 12 month data might save a failure at 18 A.J. Mullen-2/8/2006
1787Thanks Elisabeth. Everyone else has done some work here on mygn, but me. Sorrykeokalani'nui-2/8/2006
1786Meldrum et al. actually spent some time with the 10-Q, making an effort to updatscaram(o)uche-2/8/2006
1785Proc Natl Acad Sci U S A. 2006 Feb 3; [Epub ahead of print] FRET imaging reveascaram(o)uche-2/8/2006
1784I just don't believe that any risk re. hitting 0.05 is justified. Pick yourscaram(o)uche-2/8/2006
1783>> apparent to me that they are 'learning as they go along' <&lscaram(o)uche-2/8/2006
1782I just listened to the CC..I'll be arrogant and post what I think is relevanzeta1961-2/8/2006
1781I tend to agree with you LJM. By looking at the data at 12 months, with the optA.J. Mullen-2/7/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News